×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cure Connections

Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, provide their perspectives on adjusting to life with cancer of the head and neck, as a patient or as a caregiver, and share advice for those who must undergo laryngectomy. 
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, share insight into the role of novel treatment approaches like immunotherapy, robotic surgery and de-escalation in the management of cancers of the head and neck.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, review the various modalities of treatment for cancers of the head and neck and identify which physicians are responsible for delivering this care.
Itzhak Brook, M.D., M.Sc., considers how experiencing cancer of the head and neck as a patient affected his understandings as a physician and outlines available patient resources with fellow board member of the Head and Neck Cancer Alliance, Meryl Kaufman, M.Ed., CCC-SLP, BRS-S.
More

Cure Expert Connections

Sandy Liu, MD, reviews the current challenges and recent advances in the treatment of renal cell carcinoma, or kidney cancer, as well as what she looks most forward to in the coming years.
Sandy Liu, MD, offers practical advice for patients undergoing treatment for renal cell carcinoma, or kidney cancer, regarding self-education, self-advocacy and adherence to therapy.
Sandy Liu, MD, outlines the available second-line therapeutic options for renal cell carcinoma, or kidney cancer, as well as what factors she considers when selecting from agents in this setting.
Sandy Liu, MD, reflects on the value of targeted agents in the first-line treatment setting of renal cell carcinoma, or kidney cancer, given clinical and personal experience.
More

Cure TV

Maria Falzone
Despite being diagnosed with cholangiocarcinoma, a cancer of the bile duct, Maria Falzone, a safe sex speaker and comedienne, maintains her sense of humor. 
 
After testing positive for the BRCA mutation, Pulaski has become an advocate and authored a book titled “Mom’s Genes,” which focuses on starting the conversation with children about their family’s health history.
“We’re all really aware now, so what are we doing about it?” Zionna Hanson, founder of Barbells for Boobs, said. 
Amy Robach
Share your cancer story, says news anchor and survivor Amy Robach.
More
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other